Global DPT Series Vaccine Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032
According to our (Global Info Research) latest study, the global DPT Series Vaccine market size was valued at US$ 6045 million in 2025 and is forecast to a readjusted size of US$ 6737 million by 2032 with a CAGR of 1.5% during review period.
The DTP vaccine is a combination vaccine used to prevent three serious infectious diseases: pertussis, diphtheria, and tetanus. It is typically an important component of basic immunization programs for infants and young children. This vaccine is formulated by combining pertussis antigen (whole-cell or acellular), diphtheria toxoid, and tetanus toxoid, inducing the production of specific antibodies in the body to establish immune protection. Depending on the pertussis component, it can be divided into whole-cell (DTwP) and acellular (DTaP) formulations; most countries currently use the acellular formulation to reduce the risk of adverse reactions. The DTP vaccine is usually an adsorbed formulation containing aluminum salt adjuvants to enhance its immunogenicity and is one of the core vaccines in global childhood immunization programs. The global annual demand is approximately 300-400 million doses.
The DPT vaccine (Diphtheria, Pertussis, Tetanus) is a combined vaccine used to prevent three serious infectious diseases: pertussis, diphtheria, and tetanus. It is one of the core vaccines in the global infant immunization program. Depending on the pertussis component, DPT vaccines can be divided into whole-cell (DTwP) and acellular (DTaP) vaccines. Acellular vaccines, due to their lower adverse reactions, have become the mainstream product in most developed countries and emerging markets. As a high-coverage vaccine in immunization programs, the DPT vaccine market is characterized by stable and relatively inelastic demand, while continuously evolving driven by product structure upgrades and the trend towards multivalent vaccines.
In recent years, the global vaccine market has maintained steady growth, with overall childhood immunization program coverage remaining at a high level, providing a long-term stable foundation for demand for DPT vaccines. With the continuous improvement of public health systems in various countries and the increase in immunization coverage in emerging economies, the demand for DPT vaccines continues to be released. At the same time, developed country markets are gradually upgrading from traditional trivalent vaccines to quadrivalent, pentavalent, and hexavalent vaccines, driving up the value of single-dose products. The trend towards multivalent vaccines has become one of the important drivers of market growth.
From a product structure perspective, whole-cell DPT vaccines remain widely used in some developing countries due to their lower cost and stronger immunogenicity. Acellular vaccines dominate in Europe, the US, and parts of the Asia-Pacific region, gaining market favor due to their superior safety profile. Furthermore, demand for reduced-dose booster vaccines (Tdap) for adolescents and adults is gradually increasing, bringing new growth points to the market. Overall, the product structure is shifting from basic immunization to booster immunization and multivalent vaccines.
In terms of industry landscape, the global DPT vaccine market is highly concentrated. Large international vaccine companies possess technological and brand advantages in the high-end acellular and multivalent vaccine sectors, while companies in some emerging markets are competitive in cost control and local supply. With rising vaccine quality standards and stricter regulations, industry entry barriers continue to increase, making R&D capabilities and production consistency core competitive factors for companies.
Looking ahead, the global DPT vaccine market will be driven by three main factors: first, the continued advancement and increased coverage of immunization programs in various countries; second, the increased product value brought about by upgrades to multivalent vaccines; and third, the increased demand resulting from the expansion of the booster immunization population. The overall market growth pace is relatively stable, with structural upgrades becoming the main source of growth.
This report is a detailed and comprehensive analysis for global DPT Series Vaccine market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global DPT Series Vaccine market size and forecasts, in consumption value ($ Million), sales quantity (K Dose), and average selling prices (US$/Dose), 2021-2032
Global DPT Series Vaccine market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Dose), and average selling prices (US$/Dose), 2021-2032
Global DPT Series Vaccine market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Dose), and average selling prices (US$/Dose), 2021-2032
Global DPT Series Vaccine market shares of main players, shipments in revenue ($ Million), sales quantity (K Dose), and ASP (US$/Dose), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for DPT Series Vaccine
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global DPT Series Vaccine market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Sanofi, GSK, AJ Vaccines, Panacea Biotec, Sino Biopharm, Kangtai Biological Products, Walvax Biotechnology, Serum Institute of India, Bharat Biotech, Boryung Biopharama, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
DPT Series Vaccine market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe DPT Series Vaccine product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of DPT Series Vaccine, with price, sales quantity, revenue, and global market share of DPT Series Vaccine from 2021 to 2026.
Chapter 3, the DPT Series Vaccine competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the DPT Series Vaccine breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and DPT Series Vaccine market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of DPT Series Vaccine.
Chapter 14 and 15, to describe DPT Series Vaccine sales channel, distributors, customers, research findings and conclusion.
The DTP vaccine is a combination vaccine used to prevent three serious infectious diseases: pertussis, diphtheria, and tetanus. It is typically an important component of basic immunization programs for infants and young children. This vaccine is formulated by combining pertussis antigen (whole-cell or acellular), diphtheria toxoid, and tetanus toxoid, inducing the production of specific antibodies in the body to establish immune protection. Depending on the pertussis component, it can be divided into whole-cell (DTwP) and acellular (DTaP) formulations; most countries currently use the acellular formulation to reduce the risk of adverse reactions. The DTP vaccine is usually an adsorbed formulation containing aluminum salt adjuvants to enhance its immunogenicity and is one of the core vaccines in global childhood immunization programs. The global annual demand is approximately 300-400 million doses.
The DPT vaccine (Diphtheria, Pertussis, Tetanus) is a combined vaccine used to prevent three serious infectious diseases: pertussis, diphtheria, and tetanus. It is one of the core vaccines in the global infant immunization program. Depending on the pertussis component, DPT vaccines can be divided into whole-cell (DTwP) and acellular (DTaP) vaccines. Acellular vaccines, due to their lower adverse reactions, have become the mainstream product in most developed countries and emerging markets. As a high-coverage vaccine in immunization programs, the DPT vaccine market is characterized by stable and relatively inelastic demand, while continuously evolving driven by product structure upgrades and the trend towards multivalent vaccines.
In recent years, the global vaccine market has maintained steady growth, with overall childhood immunization program coverage remaining at a high level, providing a long-term stable foundation for demand for DPT vaccines. With the continuous improvement of public health systems in various countries and the increase in immunization coverage in emerging economies, the demand for DPT vaccines continues to be released. At the same time, developed country markets are gradually upgrading from traditional trivalent vaccines to quadrivalent, pentavalent, and hexavalent vaccines, driving up the value of single-dose products. The trend towards multivalent vaccines has become one of the important drivers of market growth.
From a product structure perspective, whole-cell DPT vaccines remain widely used in some developing countries due to their lower cost and stronger immunogenicity. Acellular vaccines dominate in Europe, the US, and parts of the Asia-Pacific region, gaining market favor due to their superior safety profile. Furthermore, demand for reduced-dose booster vaccines (Tdap) for adolescents and adults is gradually increasing, bringing new growth points to the market. Overall, the product structure is shifting from basic immunization to booster immunization and multivalent vaccines.
In terms of industry landscape, the global DPT vaccine market is highly concentrated. Large international vaccine companies possess technological and brand advantages in the high-end acellular and multivalent vaccine sectors, while companies in some emerging markets are competitive in cost control and local supply. With rising vaccine quality standards and stricter regulations, industry entry barriers continue to increase, making R&D capabilities and production consistency core competitive factors for companies.
Looking ahead, the global DPT vaccine market will be driven by three main factors: first, the continued advancement and increased coverage of immunization programs in various countries; second, the increased product value brought about by upgrades to multivalent vaccines; and third, the increased demand resulting from the expansion of the booster immunization population. The overall market growth pace is relatively stable, with structural upgrades becoming the main source of growth.
This report is a detailed and comprehensive analysis for global DPT Series Vaccine market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global DPT Series Vaccine market size and forecasts, in consumption value ($ Million), sales quantity (K Dose), and average selling prices (US$/Dose), 2021-2032
Global DPT Series Vaccine market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Dose), and average selling prices (US$/Dose), 2021-2032
Global DPT Series Vaccine market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Dose), and average selling prices (US$/Dose), 2021-2032
Global DPT Series Vaccine market shares of main players, shipments in revenue ($ Million), sales quantity (K Dose), and ASP (US$/Dose), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for DPT Series Vaccine
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global DPT Series Vaccine market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Sanofi, GSK, AJ Vaccines, Panacea Biotec, Sino Biopharm, Kangtai Biological Products, Walvax Biotechnology, Serum Institute of India, Bharat Biotech, Boryung Biopharama, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
DPT Series Vaccine market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
- Whole-cell DPT Vaccine
- Acellular DPT Vaccine
- Trivalent Vaccine
- Quadrivalent Vaccine
- Pentavalent Vaccine
- Others
- Basic Vaccines
- Booster Vaccines
- Public
- Private
- Sanofi
- GSK
- AJ Vaccines
- Panacea Biotec
- Sino Biopharm
- Kangtai Biological Products
- Walvax Biotechnology
- Serum Institute of India
- Bharat Biotech
- Boryung Biopharama
- Tanabe Pharma
- KM Biologics
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe DPT Series Vaccine product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of DPT Series Vaccine, with price, sales quantity, revenue, and global market share of DPT Series Vaccine from 2021 to 2026.
Chapter 3, the DPT Series Vaccine competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the DPT Series Vaccine breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and DPT Series Vaccine market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of DPT Series Vaccine.
Chapter 14 and 15, to describe DPT Series Vaccine sales channel, distributors, customers, research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global DPT Series Vaccine Consumption Value by Type: 2021 Versus 2025 Versus 2032
1.3.2 Whole-cell DPT Vaccine
1.3.3 Acellular DPT Vaccine
1.4 Market Analysis by Combination
1.4.1 Overview: Global DPT Series Vaccine Consumption Value by Combination: 2021 Versus 2025 Versus 2032
1.4.2 Trivalent Vaccine
1.4.3 Quadrivalent Vaccine
1.4.4 Pentavalent Vaccine
1.4.5 Others
1.5 Market Analysis by Effect
1.5.1 Overview: Global DPT Series Vaccine Consumption Value by Effect: 2021 Versus 2025 Versus 2032
1.5.2 Basic Vaccines
1.5.3 Booster Vaccines
1.6 Market Analysis by Application
1.6.1 Overview: Global DPT Series Vaccine Consumption Value by Application: 2021 Versus 2025 Versus 2032
1.6.2 Public
1.6.3 Private
1.7 Global DPT Series Vaccine Market Size & Forecast
1.7.1 Global DPT Series Vaccine Consumption Value (2021 & 2025 & 2032)
1.7.2 Global DPT Series Vaccine Sales Quantity (2021-2032)
1.7.3 Global DPT Series Vaccine Average Price (2021-2032)
2 MANUFACTURERS PROFILES
2.1 Sanofi
2.1.1 Sanofi Details
2.1.2 Sanofi Major Business
2.1.3 Sanofi DPT Series Vaccine Product and Services
2.1.4 Sanofi DPT Series Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.1.5 Sanofi Recent Developments/Updates
2.2 GSK
2.2.1 GSK Details
2.2.2 GSK Major Business
2.2.3 GSK DPT Series Vaccine Product and Services
2.2.4 GSK DPT Series Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.2.5 GSK Recent Developments/Updates
2.3 AJ Vaccines
2.3.1 AJ Vaccines Details
2.3.2 AJ Vaccines Major Business
2.3.3 AJ Vaccines DPT Series Vaccine Product and Services
2.3.4 AJ Vaccines DPT Series Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.3.5 AJ Vaccines Recent Developments/Updates
2.4 Panacea Biotec
2.4.1 Panacea Biotec Details
2.4.2 Panacea Biotec Major Business
2.4.3 Panacea Biotec DPT Series Vaccine Product and Services
2.4.4 Panacea Biotec DPT Series Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.4.5 Panacea Biotec Recent Developments/Updates
2.5 Sino Biopharm
2.5.1 Sino Biopharm Details
2.5.2 Sino Biopharm Major Business
2.5.3 Sino Biopharm DPT Series Vaccine Product and Services
2.5.4 Sino Biopharm DPT Series Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.5.5 Sino Biopharm Recent Developments/Updates
2.6 Kangtai Biological Products
2.6.1 Kangtai Biological Products Details
2.6.2 Kangtai Biological Products Major Business
2.6.3 Kangtai Biological Products DPT Series Vaccine Product and Services
2.6.4 Kangtai Biological Products DPT Series Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.6.5 Kangtai Biological Products Recent Developments/Updates
2.7 Walvax Biotechnology
2.7.1 Walvax Biotechnology Details
2.7.2 Walvax Biotechnology Major Business
2.7.3 Walvax Biotechnology DPT Series Vaccine Product and Services
2.7.4 Walvax Biotechnology DPT Series Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.7.5 Walvax Biotechnology Recent Developments/Updates
2.8 Serum Institute of India
2.8.1 Serum Institute of India Details
2.8.2 Serum Institute of India Major Business
2.8.3 Serum Institute of India DPT Series Vaccine Product and Services
2.8.4 Serum Institute of India DPT Series Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.8.5 Serum Institute of India Recent Developments/Updates
2.9 Bharat Biotech
2.9.1 Bharat Biotech Details
2.9.2 Bharat Biotech Major Business
2.9.3 Bharat Biotech DPT Series Vaccine Product and Services
2.9.4 Bharat Biotech DPT Series Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.9.5 Bharat Biotech Recent Developments/Updates
2.10 Boryung Biopharama
2.10.1 Boryung Biopharama Details
2.10.2 Boryung Biopharama Major Business
2.10.3 Boryung Biopharama DPT Series Vaccine Product and Services
2.10.4 Boryung Biopharama DPT Series Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.10.5 Boryung Biopharama Recent Developments/Updates
2.11 Tanabe Pharma
2.11.1 Tanabe Pharma Details
2.11.2 Tanabe Pharma Major Business
2.11.3 Tanabe Pharma DPT Series Vaccine Product and Services
2.11.4 Tanabe Pharma DPT Series Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.11.5 Tanabe Pharma Recent Developments/Updates
2.12 KM Biologics
2.12.1 KM Biologics Details
2.12.2 KM Biologics Major Business
2.12.3 KM Biologics DPT Series Vaccine Product and Services
2.12.4 KM Biologics DPT Series Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.12.5 KM Biologics Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: DPT SERIES VACCINE BY MANUFACTURER
3.1 Global DPT Series Vaccine Sales Quantity by Manufacturer (2021-2026)
3.2 Global DPT Series Vaccine Revenue by Manufacturer (2021-2026)
3.3 Global DPT Series Vaccine Average Price by Manufacturer (2021-2026)
3.4 Market Share Analysis (2025)
3.4.1 Producer Shipments of DPT Series Vaccine by Manufacturer Revenue ($MM) and Market Share (%): 2025
3.4.2 Top 3 DPT Series Vaccine Manufacturer Market Share in 2025
3.4.3 Top 6 DPT Series Vaccine Manufacturer Market Share in 2025
3.5 DPT Series Vaccine Market: Overall Company Footprint Analysis
3.5.1 DPT Series Vaccine Market: Region Footprint
3.5.2 DPT Series Vaccine Market: Company Product Type Footprint
3.5.3 DPT Series Vaccine Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global DPT Series Vaccine Market Size by Region
4.1.1 Global DPT Series Vaccine Sales Quantity by Region (2021-2032)
4.1.2 Global DPT Series Vaccine Consumption Value by Region (2021-2032)
4.1.3 Global DPT Series Vaccine Average Price by Region (2021-2032)
4.2 North America DPT Series Vaccine Consumption Value (2021-2032)
4.3 Europe DPT Series Vaccine Consumption Value (2021-2032)
4.4 Asia-Pacific DPT Series Vaccine Consumption Value (2021-2032)
4.5 South America DPT Series Vaccine Consumption Value (2021-2032)
4.6 Middle East & Africa DPT Series Vaccine Consumption Value (2021-2032)
5 MARKET SEGMENT BY TYPE
5.1 Global DPT Series Vaccine Sales Quantity by Type (2021-2032)
5.2 Global DPT Series Vaccine Consumption Value by Type (2021-2032)
5.3 Global DPT Series Vaccine Average Price by Type (2021-2032)
6 MARKET SEGMENT BY APPLICATION
6.1 Global DPT Series Vaccine Sales Quantity by Application (2021-2032)
6.2 Global DPT Series Vaccine Consumption Value by Application (2021-2032)
6.3 Global DPT Series Vaccine Average Price by Application (2021-2032)
7 NORTH AMERICA
7.1 North America DPT Series Vaccine Sales Quantity by Type (2021-2032)
7.2 North America DPT Series Vaccine Sales Quantity by Application (2021-2032)
7.3 North America DPT Series Vaccine Market Size by Country
7.3.1 North America DPT Series Vaccine Sales Quantity by Country (2021-2032)
7.3.2 North America DPT Series Vaccine Consumption Value by Country (2021-2032)
7.3.3 United States Market Size and Forecast (2021-2032)
7.3.4 Canada Market Size and Forecast (2021-2032)
7.3.5 Mexico Market Size and Forecast (2021-2032)
8 EUROPE
8.1 Europe DPT Series Vaccine Sales Quantity by Type (2021-2032)
8.2 Europe DPT Series Vaccine Sales Quantity by Application (2021-2032)
8.3 Europe DPT Series Vaccine Market Size by Country
8.3.1 Europe DPT Series Vaccine Sales Quantity by Country (2021-2032)
8.3.2 Europe DPT Series Vaccine Consumption Value by Country (2021-2032)
8.3.3 Germany Market Size and Forecast (2021-2032)
8.3.4 France Market Size and Forecast (2021-2032)
8.3.5 United Kingdom Market Size and Forecast (2021-2032)
8.3.6 Russia Market Size and Forecast (2021-2032)
8.3.7 Italy Market Size and Forecast (2021-2032)
9 ASIA-PACIFIC
9.1 Asia-Pacific DPT Series Vaccine Sales Quantity by Type (2021-2032)
9.2 Asia-Pacific DPT Series Vaccine Sales Quantity by Application (2021-2032)
9.3 Asia-Pacific DPT Series Vaccine Market Size by Region
9.3.1 Asia-Pacific DPT Series Vaccine Sales Quantity by Region (2021-2032)
9.3.2 Asia-Pacific DPT Series Vaccine Consumption Value by Region (2021-2032)
9.3.3 China Market Size and Forecast (2021-2032)
9.3.4 Japan Market Size and Forecast (2021-2032)
9.3.5 South Korea Market Size and Forecast (2021-2032)
9.3.6 India Market Size and Forecast (2021-2032)
9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
9.3.8 Australia Market Size and Forecast (2021-2032)
10 SOUTH AMERICA
10.1 South America DPT Series Vaccine Sales Quantity by Type (2021-2032)
10.2 South America DPT Series Vaccine Sales Quantity by Application (2021-2032)
10.3 South America DPT Series Vaccine Market Size by Country
10.3.1 South America DPT Series Vaccine Sales Quantity by Country (2021-2032)
10.3.2 South America DPT Series Vaccine Consumption Value by Country (2021-2032)
10.3.3 Brazil Market Size and Forecast (2021-2032)
10.3.4 Argentina Market Size and Forecast (2021-2032)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa DPT Series Vaccine Sales Quantity by Type (2021-2032)
11.2 Middle East & Africa DPT Series Vaccine Sales Quantity by Application (2021-2032)
11.3 Middle East & Africa DPT Series Vaccine Market Size by Country
11.3.1 Middle East & Africa DPT Series Vaccine Sales Quantity by Country (2021-2032)
11.3.2 Middle East & Africa DPT Series Vaccine Consumption Value by Country (2021-2032)
11.3.3 Turkey Market Size and Forecast (2021-2032)
11.3.4 Egypt Market Size and Forecast (2021-2032)
11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
11.3.6 South Africa Market Size and Forecast (2021-2032)
12 MARKET DYNAMICS
12.1 DPT Series Vaccine Market Drivers
12.2 DPT Series Vaccine Market Restraints
12.3 DPT Series Vaccine Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of DPT Series Vaccine and Key Manufacturers
13.2 Manufacturing Costs Percentage of DPT Series Vaccine
13.3 DPT Series Vaccine Production Process
13.4 Industry Value Chain Analysis
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 DPT Series Vaccine Typical Distributors
14.3 DPT Series Vaccine Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global DPT Series Vaccine Consumption Value by Type: 2021 Versus 2025 Versus 2032
1.3.2 Whole-cell DPT Vaccine
1.3.3 Acellular DPT Vaccine
1.4 Market Analysis by Combination
1.4.1 Overview: Global DPT Series Vaccine Consumption Value by Combination: 2021 Versus 2025 Versus 2032
1.4.2 Trivalent Vaccine
1.4.3 Quadrivalent Vaccine
1.4.4 Pentavalent Vaccine
1.4.5 Others
1.5 Market Analysis by Effect
1.5.1 Overview: Global DPT Series Vaccine Consumption Value by Effect: 2021 Versus 2025 Versus 2032
1.5.2 Basic Vaccines
1.5.3 Booster Vaccines
1.6 Market Analysis by Application
1.6.1 Overview: Global DPT Series Vaccine Consumption Value by Application: 2021 Versus 2025 Versus 2032
1.6.2 Public
1.6.3 Private
1.7 Global DPT Series Vaccine Market Size & Forecast
1.7.1 Global DPT Series Vaccine Consumption Value (2021 & 2025 & 2032)
1.7.2 Global DPT Series Vaccine Sales Quantity (2021-2032)
1.7.3 Global DPT Series Vaccine Average Price (2021-2032)
2 MANUFACTURERS PROFILES
2.1 Sanofi
2.1.1 Sanofi Details
2.1.2 Sanofi Major Business
2.1.3 Sanofi DPT Series Vaccine Product and Services
2.1.4 Sanofi DPT Series Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.1.5 Sanofi Recent Developments/Updates
2.2 GSK
2.2.1 GSK Details
2.2.2 GSK Major Business
2.2.3 GSK DPT Series Vaccine Product and Services
2.2.4 GSK DPT Series Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.2.5 GSK Recent Developments/Updates
2.3 AJ Vaccines
2.3.1 AJ Vaccines Details
2.3.2 AJ Vaccines Major Business
2.3.3 AJ Vaccines DPT Series Vaccine Product and Services
2.3.4 AJ Vaccines DPT Series Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.3.5 AJ Vaccines Recent Developments/Updates
2.4 Panacea Biotec
2.4.1 Panacea Biotec Details
2.4.2 Panacea Biotec Major Business
2.4.3 Panacea Biotec DPT Series Vaccine Product and Services
2.4.4 Panacea Biotec DPT Series Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.4.5 Panacea Biotec Recent Developments/Updates
2.5 Sino Biopharm
2.5.1 Sino Biopharm Details
2.5.2 Sino Biopharm Major Business
2.5.3 Sino Biopharm DPT Series Vaccine Product and Services
2.5.4 Sino Biopharm DPT Series Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.5.5 Sino Biopharm Recent Developments/Updates
2.6 Kangtai Biological Products
2.6.1 Kangtai Biological Products Details
2.6.2 Kangtai Biological Products Major Business
2.6.3 Kangtai Biological Products DPT Series Vaccine Product and Services
2.6.4 Kangtai Biological Products DPT Series Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.6.5 Kangtai Biological Products Recent Developments/Updates
2.7 Walvax Biotechnology
2.7.1 Walvax Biotechnology Details
2.7.2 Walvax Biotechnology Major Business
2.7.3 Walvax Biotechnology DPT Series Vaccine Product and Services
2.7.4 Walvax Biotechnology DPT Series Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.7.5 Walvax Biotechnology Recent Developments/Updates
2.8 Serum Institute of India
2.8.1 Serum Institute of India Details
2.8.2 Serum Institute of India Major Business
2.8.3 Serum Institute of India DPT Series Vaccine Product and Services
2.8.4 Serum Institute of India DPT Series Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.8.5 Serum Institute of India Recent Developments/Updates
2.9 Bharat Biotech
2.9.1 Bharat Biotech Details
2.9.2 Bharat Biotech Major Business
2.9.3 Bharat Biotech DPT Series Vaccine Product and Services
2.9.4 Bharat Biotech DPT Series Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.9.5 Bharat Biotech Recent Developments/Updates
2.10 Boryung Biopharama
2.10.1 Boryung Biopharama Details
2.10.2 Boryung Biopharama Major Business
2.10.3 Boryung Biopharama DPT Series Vaccine Product and Services
2.10.4 Boryung Biopharama DPT Series Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.10.5 Boryung Biopharama Recent Developments/Updates
2.11 Tanabe Pharma
2.11.1 Tanabe Pharma Details
2.11.2 Tanabe Pharma Major Business
2.11.3 Tanabe Pharma DPT Series Vaccine Product and Services
2.11.4 Tanabe Pharma DPT Series Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.11.5 Tanabe Pharma Recent Developments/Updates
2.12 KM Biologics
2.12.1 KM Biologics Details
2.12.2 KM Biologics Major Business
2.12.3 KM Biologics DPT Series Vaccine Product and Services
2.12.4 KM Biologics DPT Series Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.12.5 KM Biologics Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: DPT SERIES VACCINE BY MANUFACTURER
3.1 Global DPT Series Vaccine Sales Quantity by Manufacturer (2021-2026)
3.2 Global DPT Series Vaccine Revenue by Manufacturer (2021-2026)
3.3 Global DPT Series Vaccine Average Price by Manufacturer (2021-2026)
3.4 Market Share Analysis (2025)
3.4.1 Producer Shipments of DPT Series Vaccine by Manufacturer Revenue ($MM) and Market Share (%): 2025
3.4.2 Top 3 DPT Series Vaccine Manufacturer Market Share in 2025
3.4.3 Top 6 DPT Series Vaccine Manufacturer Market Share in 2025
3.5 DPT Series Vaccine Market: Overall Company Footprint Analysis
3.5.1 DPT Series Vaccine Market: Region Footprint
3.5.2 DPT Series Vaccine Market: Company Product Type Footprint
3.5.3 DPT Series Vaccine Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global DPT Series Vaccine Market Size by Region
4.1.1 Global DPT Series Vaccine Sales Quantity by Region (2021-2032)
4.1.2 Global DPT Series Vaccine Consumption Value by Region (2021-2032)
4.1.3 Global DPT Series Vaccine Average Price by Region (2021-2032)
4.2 North America DPT Series Vaccine Consumption Value (2021-2032)
4.3 Europe DPT Series Vaccine Consumption Value (2021-2032)
4.4 Asia-Pacific DPT Series Vaccine Consumption Value (2021-2032)
4.5 South America DPT Series Vaccine Consumption Value (2021-2032)
4.6 Middle East & Africa DPT Series Vaccine Consumption Value (2021-2032)
5 MARKET SEGMENT BY TYPE
5.1 Global DPT Series Vaccine Sales Quantity by Type (2021-2032)
5.2 Global DPT Series Vaccine Consumption Value by Type (2021-2032)
5.3 Global DPT Series Vaccine Average Price by Type (2021-2032)
6 MARKET SEGMENT BY APPLICATION
6.1 Global DPT Series Vaccine Sales Quantity by Application (2021-2032)
6.2 Global DPT Series Vaccine Consumption Value by Application (2021-2032)
6.3 Global DPT Series Vaccine Average Price by Application (2021-2032)
7 NORTH AMERICA
7.1 North America DPT Series Vaccine Sales Quantity by Type (2021-2032)
7.2 North America DPT Series Vaccine Sales Quantity by Application (2021-2032)
7.3 North America DPT Series Vaccine Market Size by Country
7.3.1 North America DPT Series Vaccine Sales Quantity by Country (2021-2032)
7.3.2 North America DPT Series Vaccine Consumption Value by Country (2021-2032)
7.3.3 United States Market Size and Forecast (2021-2032)
7.3.4 Canada Market Size and Forecast (2021-2032)
7.3.5 Mexico Market Size and Forecast (2021-2032)
8 EUROPE
8.1 Europe DPT Series Vaccine Sales Quantity by Type (2021-2032)
8.2 Europe DPT Series Vaccine Sales Quantity by Application (2021-2032)
8.3 Europe DPT Series Vaccine Market Size by Country
8.3.1 Europe DPT Series Vaccine Sales Quantity by Country (2021-2032)
8.3.2 Europe DPT Series Vaccine Consumption Value by Country (2021-2032)
8.3.3 Germany Market Size and Forecast (2021-2032)
8.3.4 France Market Size and Forecast (2021-2032)
8.3.5 United Kingdom Market Size and Forecast (2021-2032)
8.3.6 Russia Market Size and Forecast (2021-2032)
8.3.7 Italy Market Size and Forecast (2021-2032)
9 ASIA-PACIFIC
9.1 Asia-Pacific DPT Series Vaccine Sales Quantity by Type (2021-2032)
9.2 Asia-Pacific DPT Series Vaccine Sales Quantity by Application (2021-2032)
9.3 Asia-Pacific DPT Series Vaccine Market Size by Region
9.3.1 Asia-Pacific DPT Series Vaccine Sales Quantity by Region (2021-2032)
9.3.2 Asia-Pacific DPT Series Vaccine Consumption Value by Region (2021-2032)
9.3.3 China Market Size and Forecast (2021-2032)
9.3.4 Japan Market Size and Forecast (2021-2032)
9.3.5 South Korea Market Size and Forecast (2021-2032)
9.3.6 India Market Size and Forecast (2021-2032)
9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
9.3.8 Australia Market Size and Forecast (2021-2032)
10 SOUTH AMERICA
10.1 South America DPT Series Vaccine Sales Quantity by Type (2021-2032)
10.2 South America DPT Series Vaccine Sales Quantity by Application (2021-2032)
10.3 South America DPT Series Vaccine Market Size by Country
10.3.1 South America DPT Series Vaccine Sales Quantity by Country (2021-2032)
10.3.2 South America DPT Series Vaccine Consumption Value by Country (2021-2032)
10.3.3 Brazil Market Size and Forecast (2021-2032)
10.3.4 Argentina Market Size and Forecast (2021-2032)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa DPT Series Vaccine Sales Quantity by Type (2021-2032)
11.2 Middle East & Africa DPT Series Vaccine Sales Quantity by Application (2021-2032)
11.3 Middle East & Africa DPT Series Vaccine Market Size by Country
11.3.1 Middle East & Africa DPT Series Vaccine Sales Quantity by Country (2021-2032)
11.3.2 Middle East & Africa DPT Series Vaccine Consumption Value by Country (2021-2032)
11.3.3 Turkey Market Size and Forecast (2021-2032)
11.3.4 Egypt Market Size and Forecast (2021-2032)
11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
11.3.6 South Africa Market Size and Forecast (2021-2032)
12 MARKET DYNAMICS
12.1 DPT Series Vaccine Market Drivers
12.2 DPT Series Vaccine Market Restraints
12.3 DPT Series Vaccine Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of DPT Series Vaccine and Key Manufacturers
13.2 Manufacturing Costs Percentage of DPT Series Vaccine
13.3 DPT Series Vaccine Production Process
13.4 Industry Value Chain Analysis
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 DPT Series Vaccine Typical Distributors
14.3 DPT Series Vaccine Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
LIST OF TABLES
Table 1. Global DPT Series Vaccine Consumption Value by Type, (USD Million), 2021 & 2025 & 2032
Table 2. Global DPT Series Vaccine Consumption Value by Combination, (USD Million), 2021 & 2025 & 2032
Table 3. Global DPT Series Vaccine Consumption Value by Effect, (USD Million), 2021 & 2025 & 2032
Table 4. Global DPT Series Vaccine Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Table 5. Sanofi Basic Information, Manufacturing Base and Competitors
Table 6. Sanofi Major Business
Table 7. Sanofi DPT Series Vaccine Product and Services
Table 8. Sanofi DPT Series Vaccine Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 9. Sanofi Recent Developments/Updates
Table 10. GSK Basic Information, Manufacturing Base and Competitors
Table 11. GSK Major Business
Table 12. GSK DPT Series Vaccine Product and Services
Table 13. GSK DPT Series Vaccine Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 14. GSK Recent Developments/Updates
Table 15. AJ Vaccines Basic Information, Manufacturing Base and Competitors
Table 16. AJ Vaccines Major Business
Table 17. AJ Vaccines DPT Series Vaccine Product and Services
Table 18. AJ Vaccines DPT Series Vaccine Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 19. AJ Vaccines Recent Developments/Updates
Table 20. Panacea Biotec Basic Information, Manufacturing Base and Competitors
Table 21. Panacea Biotec Major Business
Table 22. Panacea Biotec DPT Series Vaccine Product and Services
Table 23. Panacea Biotec DPT Series Vaccine Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 24. Panacea Biotec Recent Developments/Updates
Table 25. Sino Biopharm Basic Information, Manufacturing Base and Competitors
Table 26. Sino Biopharm Major Business
Table 27. Sino Biopharm DPT Series Vaccine Product and Services
Table 28. Sino Biopharm DPT Series Vaccine Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 29. Sino Biopharm Recent Developments/Updates
Table 30. Kangtai Biological Products Basic Information, Manufacturing Base and Competitors
Table 31. Kangtai Biological Products Major Business
Table 32. Kangtai Biological Products DPT Series Vaccine Product and Services
Table 33. Kangtai Biological Products DPT Series Vaccine Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 34. Kangtai Biological Products Recent Developments/Updates
Table 35. Walvax Biotechnology Basic Information, Manufacturing Base and Competitors
Table 36. Walvax Biotechnology Major Business
Table 37. Walvax Biotechnology DPT Series Vaccine Product and Services
Table 38. Walvax Biotechnology DPT Series Vaccine Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 39. Walvax Biotechnology Recent Developments/Updates
Table 40. Serum Institute of India Basic Information, Manufacturing Base and Competitors
Table 41. Serum Institute of India Major Business
Table 42. Serum Institute of India DPT Series Vaccine Product and Services
Table 43. Serum Institute of India DPT Series Vaccine Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 44. Serum Institute of India Recent Developments/Updates
Table 45. Bharat Biotech Basic Information, Manufacturing Base and Competitors
Table 46. Bharat Biotech Major Business
Table 47. Bharat Biotech DPT Series Vaccine Product and Services
Table 48. Bharat Biotech DPT Series Vaccine Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 49. Bharat Biotech Recent Developments/Updates
Table 50. Boryung Biopharama Basic Information, Manufacturing Base and Competitors
Table 51. Boryung Biopharama Major Business
Table 52. Boryung Biopharama DPT Series Vaccine Product and Services
Table 53. Boryung Biopharama DPT Series Vaccine Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 54. Boryung Biopharama Recent Developments/Updates
Table 55. Tanabe Pharma Basic Information, Manufacturing Base and Competitors
Table 56. Tanabe Pharma Major Business
Table 57. Tanabe Pharma DPT Series Vaccine Product and Services
Table 58. Tanabe Pharma DPT Series Vaccine Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 59. Tanabe Pharma Recent Developments/Updates
Table 60. KM Biologics Basic Information, Manufacturing Base and Competitors
Table 61. KM Biologics Major Business
Table 62. KM Biologics DPT Series Vaccine Product and Services
Table 63. KM Biologics DPT Series Vaccine Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 64. KM Biologics Recent Developments/Updates
Table 65. Global DPT Series Vaccine Sales Quantity by Manufacturer (2021-2026) & (K Dose)
Table 66. Global DPT Series Vaccine Revenue by Manufacturer (2021-2026) & (USD Million)
Table 67. Global DPT Series Vaccine Average Price by Manufacturer (2021-2026) & (US$/Dose)
Table 68. Market Position of Manufacturers in DPT Series Vaccine, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2025
Table 69. Head Office and DPT Series Vaccine Production Site of Key Manufacturer
Table 70. DPT Series Vaccine Market: Company Product Type Footprint
Table 71. DPT Series Vaccine Market: Company Product Application Footprint
Table 72. DPT Series Vaccine New Market Entrants and Barriers to Market Entry
Table 73. DPT Series Vaccine Mergers, Acquisition, Agreements, and Collaborations
Table 74. Global DPT Series Vaccine Consumption Value by Region (2021-2025-2032) & (USD Million) & CAGR
Table 75. Global DPT Series Vaccine Sales Quantity by Region (2021-2026) & (K Dose)
Table 76. Global DPT Series Vaccine Sales Quantity by Region (2027-2032) & (K Dose)
Table 77. Global DPT Series Vaccine Consumption Value by Region (2021-2026) & (USD Million)
Table 78. Global DPT Series Vaccine Consumption Value by Region (2027-2032) & (USD Million)
Table 79. Global DPT Series Vaccine Average Price by Region (2021-2026) & (US$/Dose)
Table 80. Global DPT Series Vaccine Average Price by Region (2027-2032) & (US$/Dose)
Table 81. Global DPT Series Vaccine Sales Quantity by Type (2021-2026) & (K Dose)
Table 82. Global DPT Series Vaccine Sales Quantity by Type (2027-2032) & (K Dose)
Table 83. Global DPT Series Vaccine Consumption Value by Type (2021-2026) & (USD Million)
Table 84. Global DPT Series Vaccine Consumption Value by Type (2027-2032) & (USD Million)
Table 85. Global DPT Series Vaccine Average Price by Type (2021-2026) & (US$/Dose)
Table 86. Global DPT Series Vaccine Average Price by Type (2027-2032) & (US$/Dose)
Table 87. Global DPT Series Vaccine Sales Quantity by Application (2021-2026) & (K Dose)
Table 88. Global DPT Series Vaccine Sales Quantity by Application (2027-2032) & (K Dose)
Table 89. Global DPT Series Vaccine Consumption Value by Application (2021-2026) & (USD Million)
Table 90. Global DPT Series Vaccine Consumption Value by Application (2027-2032) & (USD Million)
Table 91. Global DPT Series Vaccine Average Price by Application (2021-2026) & (US$/Dose)
Table 92. Global DPT Series Vaccine Average Price by Application (2027-2032) & (US$/Dose)
Table 93. North America DPT Series Vaccine Sales Quantity by Type (2021-2026) & (K Dose)
Table 94. North America DPT Series Vaccine Sales Quantity by Type (2027-2032) & (K Dose)
Table 95. North America DPT Series Vaccine Sales Quantity by Application (2021-2026) & (K Dose)
Table 96. North America DPT Series Vaccine Sales Quantity by Application (2027-2032) & (K Dose)
Table 97. North America DPT Series Vaccine Sales Quantity by Country (2021-2026) & (K Dose)
Table 98. North America DPT Series Vaccine Sales Quantity by Country (2027-2032) & (K Dose)
Table 99. North America DPT Series Vaccine Consumption Value by Country (2021-2026) & (USD Million)
Table 100. North America DPT Series Vaccine Consumption Value by Country (2027-2032) & (USD Million)
Table 101. Europe DPT Series Vaccine Sales Quantity by Type (2021-2026) & (K Dose)
Table 102. Europe DPT Series Vaccine Sales Quantity by Type (2027-2032) & (K Dose)
Table 103. Europe DPT Series Vaccine Sales Quantity by Application (2021-2026) & (K Dose)
Table 104. Europe DPT Series Vaccine Sales Quantity by Application (2027-2032) & (K Dose)
Table 105. Europe DPT Series Vaccine Sales Quantity by Country (2021-2026) & (K Dose)
Table 106. Europe DPT Series Vaccine Sales Quantity by Country (2027-2032) & (K Dose)
Table 107. Europe DPT Series Vaccine Consumption Value by Country (2021-2026) & (USD Million)
Table 108. Europe DPT Series Vaccine Consumption Value by Country (2027-2032) & (USD Million)
Table 109. Asia-Pacific DPT Series Vaccine Sales Quantity by Type (2021-2026) & (K Dose)
Table 110. Asia-Pacific DPT Series Vaccine Sales Quantity by Type (2027-2032) & (K Dose)
Table 111. Asia-Pacific DPT Series Vaccine Sales Quantity by Application (2021-2026) & (K Dose)
Table 112. Asia-Pacific DPT Series Vaccine Sales Quantity by Application (2027-2032) & (K Dose)
Table 113. Asia-Pacific DPT Series Vaccine Sales Quantity by Region (2021-2026) & (K Dose)
Table 114. Asia-Pacific DPT Series Vaccine Sales Quantity by Region (2027-2032) & (K Dose)
Table 115. Asia-Pacific DPT Series Vaccine Consumption Value by Region (2021-2026) & (USD Million)
Table 116. Asia-Pacific DPT Series Vaccine Consumption Value by Region (2027-2032) & (USD Million)
Table 117. South America DPT Series Vaccine Sales Quantity by Type (2021-2026) & (K Dose)
Table 118. South America DPT Series Vaccine Sales Quantity by Type (2027-2032) & (K Dose)
Table 119. South America DPT Series Vaccine Sales Quantity by Application (2021-2026) & (K Dose)
Table 120. South America DPT Series Vaccine Sales Quantity by Application (2027-2032) & (K Dose)
Table 121. South America DPT Series Vaccine Sales Quantity by Country (2021-2026) & (K Dose)
Table 122. South America DPT Series Vaccine Sales Quantity by Country (2027-2032) & (K Dose)
Table 123. South America DPT Series Vaccine Consumption Value by Country (2021-2026) & (USD Million)
Table 124. South America DPT Series Vaccine Consumption Value by Country (2027-2032) & (USD Million)
Table 125. Middle East & Africa DPT Series Vaccine Sales Quantity by Type (2021-2026) & (K Dose)
Table 126. Middle East & Africa DPT Series Vaccine Sales Quantity by Type (2027-2032) & (K Dose)
Table 127. Middle East & Africa DPT Series Vaccine Sales Quantity by Application (2021-2026) & (K Dose)
Table 128. Middle East & Africa DPT Series Vaccine Sales Quantity by Application (2027-2032) & (K Dose)
Table 129. Middle East & Africa DPT Series Vaccine Sales Quantity by Country (2021-2026) & (K Dose)
Table 130. Middle East & Africa DPT Series Vaccine Sales Quantity by Country (2027-2032) & (K Dose)
Table 131. Middle East & Africa DPT Series Vaccine Consumption Value by Country (2021-2026) & (USD Million)
Table 132. Middle East & Africa DPT Series Vaccine Consumption Value by Country (2027-2032) & (USD Million)
Table 133. DPT Series Vaccine Raw Material
Table 134. Key Manufacturers of DPT Series Vaccine Raw Materials
Table 135. DPT Series Vaccine Typical Distributors
Table 136. DPT Series Vaccine Typical Customers
Table 1. Global DPT Series Vaccine Consumption Value by Type, (USD Million), 2021 & 2025 & 2032
Table 2. Global DPT Series Vaccine Consumption Value by Combination, (USD Million), 2021 & 2025 & 2032
Table 3. Global DPT Series Vaccine Consumption Value by Effect, (USD Million), 2021 & 2025 & 2032
Table 4. Global DPT Series Vaccine Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Table 5. Sanofi Basic Information, Manufacturing Base and Competitors
Table 6. Sanofi Major Business
Table 7. Sanofi DPT Series Vaccine Product and Services
Table 8. Sanofi DPT Series Vaccine Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 9. Sanofi Recent Developments/Updates
Table 10. GSK Basic Information, Manufacturing Base and Competitors
Table 11. GSK Major Business
Table 12. GSK DPT Series Vaccine Product and Services
Table 13. GSK DPT Series Vaccine Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 14. GSK Recent Developments/Updates
Table 15. AJ Vaccines Basic Information, Manufacturing Base and Competitors
Table 16. AJ Vaccines Major Business
Table 17. AJ Vaccines DPT Series Vaccine Product and Services
Table 18. AJ Vaccines DPT Series Vaccine Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 19. AJ Vaccines Recent Developments/Updates
Table 20. Panacea Biotec Basic Information, Manufacturing Base and Competitors
Table 21. Panacea Biotec Major Business
Table 22. Panacea Biotec DPT Series Vaccine Product and Services
Table 23. Panacea Biotec DPT Series Vaccine Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 24. Panacea Biotec Recent Developments/Updates
Table 25. Sino Biopharm Basic Information, Manufacturing Base and Competitors
Table 26. Sino Biopharm Major Business
Table 27. Sino Biopharm DPT Series Vaccine Product and Services
Table 28. Sino Biopharm DPT Series Vaccine Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 29. Sino Biopharm Recent Developments/Updates
Table 30. Kangtai Biological Products Basic Information, Manufacturing Base and Competitors
Table 31. Kangtai Biological Products Major Business
Table 32. Kangtai Biological Products DPT Series Vaccine Product and Services
Table 33. Kangtai Biological Products DPT Series Vaccine Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 34. Kangtai Biological Products Recent Developments/Updates
Table 35. Walvax Biotechnology Basic Information, Manufacturing Base and Competitors
Table 36. Walvax Biotechnology Major Business
Table 37. Walvax Biotechnology DPT Series Vaccine Product and Services
Table 38. Walvax Biotechnology DPT Series Vaccine Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 39. Walvax Biotechnology Recent Developments/Updates
Table 40. Serum Institute of India Basic Information, Manufacturing Base and Competitors
Table 41. Serum Institute of India Major Business
Table 42. Serum Institute of India DPT Series Vaccine Product and Services
Table 43. Serum Institute of India DPT Series Vaccine Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 44. Serum Institute of India Recent Developments/Updates
Table 45. Bharat Biotech Basic Information, Manufacturing Base and Competitors
Table 46. Bharat Biotech Major Business
Table 47. Bharat Biotech DPT Series Vaccine Product and Services
Table 48. Bharat Biotech DPT Series Vaccine Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 49. Bharat Biotech Recent Developments/Updates
Table 50. Boryung Biopharama Basic Information, Manufacturing Base and Competitors
Table 51. Boryung Biopharama Major Business
Table 52. Boryung Biopharama DPT Series Vaccine Product and Services
Table 53. Boryung Biopharama DPT Series Vaccine Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 54. Boryung Biopharama Recent Developments/Updates
Table 55. Tanabe Pharma Basic Information, Manufacturing Base and Competitors
Table 56. Tanabe Pharma Major Business
Table 57. Tanabe Pharma DPT Series Vaccine Product and Services
Table 58. Tanabe Pharma DPT Series Vaccine Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 59. Tanabe Pharma Recent Developments/Updates
Table 60. KM Biologics Basic Information, Manufacturing Base and Competitors
Table 61. KM Biologics Major Business
Table 62. KM Biologics DPT Series Vaccine Product and Services
Table 63. KM Biologics DPT Series Vaccine Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 64. KM Biologics Recent Developments/Updates
Table 65. Global DPT Series Vaccine Sales Quantity by Manufacturer (2021-2026) & (K Dose)
Table 66. Global DPT Series Vaccine Revenue by Manufacturer (2021-2026) & (USD Million)
Table 67. Global DPT Series Vaccine Average Price by Manufacturer (2021-2026) & (US$/Dose)
Table 68. Market Position of Manufacturers in DPT Series Vaccine, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2025
Table 69. Head Office and DPT Series Vaccine Production Site of Key Manufacturer
Table 70. DPT Series Vaccine Market: Company Product Type Footprint
Table 71. DPT Series Vaccine Market: Company Product Application Footprint
Table 72. DPT Series Vaccine New Market Entrants and Barriers to Market Entry
Table 73. DPT Series Vaccine Mergers, Acquisition, Agreements, and Collaborations
Table 74. Global DPT Series Vaccine Consumption Value by Region (2021-2025-2032) & (USD Million) & CAGR
Table 75. Global DPT Series Vaccine Sales Quantity by Region (2021-2026) & (K Dose)
Table 76. Global DPT Series Vaccine Sales Quantity by Region (2027-2032) & (K Dose)
Table 77. Global DPT Series Vaccine Consumption Value by Region (2021-2026) & (USD Million)
Table 78. Global DPT Series Vaccine Consumption Value by Region (2027-2032) & (USD Million)
Table 79. Global DPT Series Vaccine Average Price by Region (2021-2026) & (US$/Dose)
Table 80. Global DPT Series Vaccine Average Price by Region (2027-2032) & (US$/Dose)
Table 81. Global DPT Series Vaccine Sales Quantity by Type (2021-2026) & (K Dose)
Table 82. Global DPT Series Vaccine Sales Quantity by Type (2027-2032) & (K Dose)
Table 83. Global DPT Series Vaccine Consumption Value by Type (2021-2026) & (USD Million)
Table 84. Global DPT Series Vaccine Consumption Value by Type (2027-2032) & (USD Million)
Table 85. Global DPT Series Vaccine Average Price by Type (2021-2026) & (US$/Dose)
Table 86. Global DPT Series Vaccine Average Price by Type (2027-2032) & (US$/Dose)
Table 87. Global DPT Series Vaccine Sales Quantity by Application (2021-2026) & (K Dose)
Table 88. Global DPT Series Vaccine Sales Quantity by Application (2027-2032) & (K Dose)
Table 89. Global DPT Series Vaccine Consumption Value by Application (2021-2026) & (USD Million)
Table 90. Global DPT Series Vaccine Consumption Value by Application (2027-2032) & (USD Million)
Table 91. Global DPT Series Vaccine Average Price by Application (2021-2026) & (US$/Dose)
Table 92. Global DPT Series Vaccine Average Price by Application (2027-2032) & (US$/Dose)
Table 93. North America DPT Series Vaccine Sales Quantity by Type (2021-2026) & (K Dose)
Table 94. North America DPT Series Vaccine Sales Quantity by Type (2027-2032) & (K Dose)
Table 95. North America DPT Series Vaccine Sales Quantity by Application (2021-2026) & (K Dose)
Table 96. North America DPT Series Vaccine Sales Quantity by Application (2027-2032) & (K Dose)
Table 97. North America DPT Series Vaccine Sales Quantity by Country (2021-2026) & (K Dose)
Table 98. North America DPT Series Vaccine Sales Quantity by Country (2027-2032) & (K Dose)
Table 99. North America DPT Series Vaccine Consumption Value by Country (2021-2026) & (USD Million)
Table 100. North America DPT Series Vaccine Consumption Value by Country (2027-2032) & (USD Million)
Table 101. Europe DPT Series Vaccine Sales Quantity by Type (2021-2026) & (K Dose)
Table 102. Europe DPT Series Vaccine Sales Quantity by Type (2027-2032) & (K Dose)
Table 103. Europe DPT Series Vaccine Sales Quantity by Application (2021-2026) & (K Dose)
Table 104. Europe DPT Series Vaccine Sales Quantity by Application (2027-2032) & (K Dose)
Table 105. Europe DPT Series Vaccine Sales Quantity by Country (2021-2026) & (K Dose)
Table 106. Europe DPT Series Vaccine Sales Quantity by Country (2027-2032) & (K Dose)
Table 107. Europe DPT Series Vaccine Consumption Value by Country (2021-2026) & (USD Million)
Table 108. Europe DPT Series Vaccine Consumption Value by Country (2027-2032) & (USD Million)
Table 109. Asia-Pacific DPT Series Vaccine Sales Quantity by Type (2021-2026) & (K Dose)
Table 110. Asia-Pacific DPT Series Vaccine Sales Quantity by Type (2027-2032) & (K Dose)
Table 111. Asia-Pacific DPT Series Vaccine Sales Quantity by Application (2021-2026) & (K Dose)
Table 112. Asia-Pacific DPT Series Vaccine Sales Quantity by Application (2027-2032) & (K Dose)
Table 113. Asia-Pacific DPT Series Vaccine Sales Quantity by Region (2021-2026) & (K Dose)
Table 114. Asia-Pacific DPT Series Vaccine Sales Quantity by Region (2027-2032) & (K Dose)
Table 115. Asia-Pacific DPT Series Vaccine Consumption Value by Region (2021-2026) & (USD Million)
Table 116. Asia-Pacific DPT Series Vaccine Consumption Value by Region (2027-2032) & (USD Million)
Table 117. South America DPT Series Vaccine Sales Quantity by Type (2021-2026) & (K Dose)
Table 118. South America DPT Series Vaccine Sales Quantity by Type (2027-2032) & (K Dose)
Table 119. South America DPT Series Vaccine Sales Quantity by Application (2021-2026) & (K Dose)
Table 120. South America DPT Series Vaccine Sales Quantity by Application (2027-2032) & (K Dose)
Table 121. South America DPT Series Vaccine Sales Quantity by Country (2021-2026) & (K Dose)
Table 122. South America DPT Series Vaccine Sales Quantity by Country (2027-2032) & (K Dose)
Table 123. South America DPT Series Vaccine Consumption Value by Country (2021-2026) & (USD Million)
Table 124. South America DPT Series Vaccine Consumption Value by Country (2027-2032) & (USD Million)
Table 125. Middle East & Africa DPT Series Vaccine Sales Quantity by Type (2021-2026) & (K Dose)
Table 126. Middle East & Africa DPT Series Vaccine Sales Quantity by Type (2027-2032) & (K Dose)
Table 127. Middle East & Africa DPT Series Vaccine Sales Quantity by Application (2021-2026) & (K Dose)
Table 128. Middle East & Africa DPT Series Vaccine Sales Quantity by Application (2027-2032) & (K Dose)
Table 129. Middle East & Africa DPT Series Vaccine Sales Quantity by Country (2021-2026) & (K Dose)
Table 130. Middle East & Africa DPT Series Vaccine Sales Quantity by Country (2027-2032) & (K Dose)
Table 131. Middle East & Africa DPT Series Vaccine Consumption Value by Country (2021-2026) & (USD Million)
Table 132. Middle East & Africa DPT Series Vaccine Consumption Value by Country (2027-2032) & (USD Million)
Table 133. DPT Series Vaccine Raw Material
Table 134. Key Manufacturers of DPT Series Vaccine Raw Materials
Table 135. DPT Series Vaccine Typical Distributors
Table 136. DPT Series Vaccine Typical Customers
LIST OF FIGURES
Figure 1. DPT Series Vaccine Picture
Figure 2. Global DPT Series Vaccine Revenue by Type, (USD Million), 2021 & 2025 & 2032
Figure 3. Global DPT Series Vaccine Revenue Market Share by Type in 2025
Figure 4. Whole-cell DPT Vaccine Examples
Figure 5. Acellular DPT Vaccine Examples
Figure 6. Global DPT Series Vaccine Revenue by Combination, (USD Million), 2021 & 2025 & 2032
Figure 7. Global DPT Series Vaccine Revenue Market Share by Combination in 2025
Figure 8. Trivalent Vaccine Examples
Figure 9. Quadrivalent Vaccine Examples
Figure 10. Pentavalent Vaccine Examples
Figure 11. Others Examples
Figure 12. Global DPT Series Vaccine Revenue by Effect, (USD Million), 2021 & 2025 & 2032
Figure 13. Global DPT Series Vaccine Revenue Market Share by Effect in 2025
Figure 14. Basic Vaccines Examples
Figure 15. Booster Vaccines Examples
Figure 16. Global DPT Series Vaccine Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 17. Global DPT Series Vaccine Revenue Market Share by Application in 2025
Figure 18. Public Examples
Figure 19. Private Examples
Figure 20. Global DPT Series Vaccine Consumption Value, (USD Million): 2021 & 2025 & 2032
Figure 21. Global DPT Series Vaccine Consumption Value and Forecast (2021-2032) & (USD Million)
Figure 22. Global DPT Series Vaccine Sales Quantity (2021-2032) & (K Dose)
Figure 23. Global DPT Series Vaccine Price (2021-2032) & (US$/Dose)
Figure 24. Global DPT Series Vaccine Sales Quantity Market Share by Manufacturer in 2025
Figure 25. Global DPT Series Vaccine Revenue Market Share by Manufacturer in 2025
Figure 26. Producer Shipments of DPT Series Vaccine by Manufacturer Sales ($MM) and Market Share (%): 2025
Figure 27. Top 3 DPT Series Vaccine Manufacturer (Revenue) Market Share in 2025
Figure 28. Top 6 DPT Series Vaccine Manufacturer (Revenue) Market Share in 2025
Figure 29. Global DPT Series Vaccine Sales Quantity Market Share by Region (2021-2032)
Figure 30. Global DPT Series Vaccine Consumption Value Market Share by Region (2021-2032)
Figure 31. North America DPT Series Vaccine Consumption Value (2021-2032) & (USD Million)
Figure 32. Europe DPT Series Vaccine Consumption Value (2021-2032) & (USD Million)
Figure 33. Asia-Pacific DPT Series Vaccine Consumption Value (2021-2032) & (USD Million)
Figure 34. South America DPT Series Vaccine Consumption Value (2021-2032) & (USD Million)
Figure 35. Middle East & Africa DPT Series Vaccine Consumption Value (2021-2032) & (USD Million)
Figure 36. Global DPT Series Vaccine Sales Quantity Market Share by Type (2021-2032)
Figure 37. Global DPT Series Vaccine Consumption Value Market Share by Type (2021-2032)
Figure 38. Global DPT Series Vaccine Average Price by Type (2021-2032) & (US$/Dose)
Figure 39. Global DPT Series Vaccine Sales Quantity Market Share by Application (2021-2032)
Figure 40. Global DPT Series Vaccine Revenue Market Share by Application (2021-2032)
Figure 41. Global DPT Series Vaccine Average Price by Application (2021-2032) & (US$/Dose)
Figure 42. North America DPT Series Vaccine Sales Quantity Market Share by Type (2021-2032)
Figure 43. North America DPT Series Vaccine Sales Quantity Market Share by Application (2021-2032)
Figure 44. North America DPT Series Vaccine Sales Quantity Market Share by Country (2021-2032)
Figure 45. North America DPT Series Vaccine Consumption Value Market Share by Country (2021-2032)
Figure 46. United States DPT Series Vaccine Consumption Value (2021-2032) & (USD Million)
Figure 47. Canada DPT Series Vaccine Consumption Value (2021-2032) & (USD Million)
Figure 48. Mexico DPT Series Vaccine Consumption Value (2021-2032) & (USD Million)
Figure 49. Europe DPT Series Vaccine Sales Quantity Market Share by Type (2021-2032)
Figure 50. Europe DPT Series Vaccine Sales Quantity Market Share by Application (2021-2032)
Figure 51. Europe DPT Series Vaccine Sales Quantity Market Share by Country (2021-2032)
Figure 52. Europe DPT Series Vaccine Consumption Value Market Share by Country (2021-2032)
Figure 53. Germany DPT Series Vaccine Consumption Value (2021-2032) & (USD Million)
Figure 54. France DPT Series Vaccine Consumption Value (2021-2032) & (USD Million)
Figure 55. United Kingdom DPT Series Vaccine Consumption Value (2021-2032) & (USD Million)
Figure 56. Russia DPT Series Vaccine Consumption Value (2021-2032) & (USD Million)
Figure 57. Italy DPT Series Vaccine Consumption Value (2021-2032) & (USD Million)
Figure 58. Asia-Pacific DPT Series Vaccine Sales Quantity Market Share by Type (2021-2032)
Figure 59. Asia-Pacific DPT Series Vaccine Sales Quantity Market Share by Application (2021-2032)
Figure 60. Asia-Pacific DPT Series Vaccine Sales Quantity Market Share by Region (2021-2032)
Figure 61. Asia-Pacific DPT Series Vaccine Consumption Value Market Share by Region (2021-2032)
Figure 62. China DPT Series Vaccine Consumption Value (2021-2032) & (USD Million)
Figure 63. Japan DPT Series Vaccine Consumption Value (2021-2032) & (USD Million)
Figure 64. South Korea DPT Series Vaccine Consumption Value (2021-2032) & (USD Million)
Figure 65. India DPT Series Vaccine Consumption Value (2021-2032) & (USD Million)
Figure 66. Southeast Asia DPT Series Vaccine Consumption Value (2021-2032) & (USD Million)
Figure 67. Australia DPT Series Vaccine Consumption Value (2021-2032) & (USD Million)
Figure 68. South America DPT Series Vaccine Sales Quantity Market Share by Type (2021-2032)
Figure 69. South America DPT Series Vaccine Sales Quantity Market Share by Application (2021-2032)
Figure 70. South America DPT Series Vaccine Sales Quantity Market Share by Country (2021-2032)
Figure 71. South America DPT Series Vaccine Consumption Value Market Share by Country (2021-2032)
Figure 72. Brazil DPT Series Vaccine Consumption Value (2021-2032) & (USD Million)
Figure 73. Argentina DPT Series Vaccine Consumption Value (2021-2032) & (USD Million)
Figure 74. Middle East & Africa DPT Series Vaccine Sales Quantity Market Share by Type (2021-2032)
Figure 75. Middle East & Africa DPT Series Vaccine Sales Quantity Market Share by Application (2021-2032)
Figure 76. Middle East & Africa DPT Series Vaccine Sales Quantity Market Share by Country (2021-2032)
Figure 77. Middle East & Africa DPT Series Vaccine Consumption Value Market Share by Country (2021-2032)
Figure 78. Turkey DPT Series Vaccine Consumption Value (2021-2032) & (USD Million)
Figure 79. Egypt DPT Series Vaccine Consumption Value (2021-2032) & (USD Million)
Figure 80. Saudi Arabia DPT Series Vaccine Consumption Value (2021-2032) & (USD Million)
Figure 81. South Africa DPT Series Vaccine Consumption Value (2021-2032) & (USD Million)
Figure 82. DPT Series Vaccine Market Drivers
Figure 83. DPT Series Vaccine Market Restraints
Figure 84. DPT Series Vaccine Market Trends
Figure 85. Porters Five Forces Analysis
Figure 86. Manufacturing Cost Structure Analysis of DPT Series Vaccine in 2025
Figure 87. Manufacturing Process Analysis of DPT Series Vaccine
Figure 88. DPT Series Vaccine Industrial Chain
Figure 89. Sales Channel: Direct to End-User vs Distributors
Figure 90. Direct Channel Pros & Cons
Figure 91. Indirect Channel Pros & Cons
Figure 92. Methodology
Figure 93. Research Process and Data Source
Figure 1. DPT Series Vaccine Picture
Figure 2. Global DPT Series Vaccine Revenue by Type, (USD Million), 2021 & 2025 & 2032
Figure 3. Global DPT Series Vaccine Revenue Market Share by Type in 2025
Figure 4. Whole-cell DPT Vaccine Examples
Figure 5. Acellular DPT Vaccine Examples
Figure 6. Global DPT Series Vaccine Revenue by Combination, (USD Million), 2021 & 2025 & 2032
Figure 7. Global DPT Series Vaccine Revenue Market Share by Combination in 2025
Figure 8. Trivalent Vaccine Examples
Figure 9. Quadrivalent Vaccine Examples
Figure 10. Pentavalent Vaccine Examples
Figure 11. Others Examples
Figure 12. Global DPT Series Vaccine Revenue by Effect, (USD Million), 2021 & 2025 & 2032
Figure 13. Global DPT Series Vaccine Revenue Market Share by Effect in 2025
Figure 14. Basic Vaccines Examples
Figure 15. Booster Vaccines Examples
Figure 16. Global DPT Series Vaccine Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 17. Global DPT Series Vaccine Revenue Market Share by Application in 2025
Figure 18. Public Examples
Figure 19. Private Examples
Figure 20. Global DPT Series Vaccine Consumption Value, (USD Million): 2021 & 2025 & 2032
Figure 21. Global DPT Series Vaccine Consumption Value and Forecast (2021-2032) & (USD Million)
Figure 22. Global DPT Series Vaccine Sales Quantity (2021-2032) & (K Dose)
Figure 23. Global DPT Series Vaccine Price (2021-2032) & (US$/Dose)
Figure 24. Global DPT Series Vaccine Sales Quantity Market Share by Manufacturer in 2025
Figure 25. Global DPT Series Vaccine Revenue Market Share by Manufacturer in 2025
Figure 26. Producer Shipments of DPT Series Vaccine by Manufacturer Sales ($MM) and Market Share (%): 2025
Figure 27. Top 3 DPT Series Vaccine Manufacturer (Revenue) Market Share in 2025
Figure 28. Top 6 DPT Series Vaccine Manufacturer (Revenue) Market Share in 2025
Figure 29. Global DPT Series Vaccine Sales Quantity Market Share by Region (2021-2032)
Figure 30. Global DPT Series Vaccine Consumption Value Market Share by Region (2021-2032)
Figure 31. North America DPT Series Vaccine Consumption Value (2021-2032) & (USD Million)
Figure 32. Europe DPT Series Vaccine Consumption Value (2021-2032) & (USD Million)
Figure 33. Asia-Pacific DPT Series Vaccine Consumption Value (2021-2032) & (USD Million)
Figure 34. South America DPT Series Vaccine Consumption Value (2021-2032) & (USD Million)
Figure 35. Middle East & Africa DPT Series Vaccine Consumption Value (2021-2032) & (USD Million)
Figure 36. Global DPT Series Vaccine Sales Quantity Market Share by Type (2021-2032)
Figure 37. Global DPT Series Vaccine Consumption Value Market Share by Type (2021-2032)
Figure 38. Global DPT Series Vaccine Average Price by Type (2021-2032) & (US$/Dose)
Figure 39. Global DPT Series Vaccine Sales Quantity Market Share by Application (2021-2032)
Figure 40. Global DPT Series Vaccine Revenue Market Share by Application (2021-2032)
Figure 41. Global DPT Series Vaccine Average Price by Application (2021-2032) & (US$/Dose)
Figure 42. North America DPT Series Vaccine Sales Quantity Market Share by Type (2021-2032)
Figure 43. North America DPT Series Vaccine Sales Quantity Market Share by Application (2021-2032)
Figure 44. North America DPT Series Vaccine Sales Quantity Market Share by Country (2021-2032)
Figure 45. North America DPT Series Vaccine Consumption Value Market Share by Country (2021-2032)
Figure 46. United States DPT Series Vaccine Consumption Value (2021-2032) & (USD Million)
Figure 47. Canada DPT Series Vaccine Consumption Value (2021-2032) & (USD Million)
Figure 48. Mexico DPT Series Vaccine Consumption Value (2021-2032) & (USD Million)
Figure 49. Europe DPT Series Vaccine Sales Quantity Market Share by Type (2021-2032)
Figure 50. Europe DPT Series Vaccine Sales Quantity Market Share by Application (2021-2032)
Figure 51. Europe DPT Series Vaccine Sales Quantity Market Share by Country (2021-2032)
Figure 52. Europe DPT Series Vaccine Consumption Value Market Share by Country (2021-2032)
Figure 53. Germany DPT Series Vaccine Consumption Value (2021-2032) & (USD Million)
Figure 54. France DPT Series Vaccine Consumption Value (2021-2032) & (USD Million)
Figure 55. United Kingdom DPT Series Vaccine Consumption Value (2021-2032) & (USD Million)
Figure 56. Russia DPT Series Vaccine Consumption Value (2021-2032) & (USD Million)
Figure 57. Italy DPT Series Vaccine Consumption Value (2021-2032) & (USD Million)
Figure 58. Asia-Pacific DPT Series Vaccine Sales Quantity Market Share by Type (2021-2032)
Figure 59. Asia-Pacific DPT Series Vaccine Sales Quantity Market Share by Application (2021-2032)
Figure 60. Asia-Pacific DPT Series Vaccine Sales Quantity Market Share by Region (2021-2032)
Figure 61. Asia-Pacific DPT Series Vaccine Consumption Value Market Share by Region (2021-2032)
Figure 62. China DPT Series Vaccine Consumption Value (2021-2032) & (USD Million)
Figure 63. Japan DPT Series Vaccine Consumption Value (2021-2032) & (USD Million)
Figure 64. South Korea DPT Series Vaccine Consumption Value (2021-2032) & (USD Million)
Figure 65. India DPT Series Vaccine Consumption Value (2021-2032) & (USD Million)
Figure 66. Southeast Asia DPT Series Vaccine Consumption Value (2021-2032) & (USD Million)
Figure 67. Australia DPT Series Vaccine Consumption Value (2021-2032) & (USD Million)
Figure 68. South America DPT Series Vaccine Sales Quantity Market Share by Type (2021-2032)
Figure 69. South America DPT Series Vaccine Sales Quantity Market Share by Application (2021-2032)
Figure 70. South America DPT Series Vaccine Sales Quantity Market Share by Country (2021-2032)
Figure 71. South America DPT Series Vaccine Consumption Value Market Share by Country (2021-2032)
Figure 72. Brazil DPT Series Vaccine Consumption Value (2021-2032) & (USD Million)
Figure 73. Argentina DPT Series Vaccine Consumption Value (2021-2032) & (USD Million)
Figure 74. Middle East & Africa DPT Series Vaccine Sales Quantity Market Share by Type (2021-2032)
Figure 75. Middle East & Africa DPT Series Vaccine Sales Quantity Market Share by Application (2021-2032)
Figure 76. Middle East & Africa DPT Series Vaccine Sales Quantity Market Share by Country (2021-2032)
Figure 77. Middle East & Africa DPT Series Vaccine Consumption Value Market Share by Country (2021-2032)
Figure 78. Turkey DPT Series Vaccine Consumption Value (2021-2032) & (USD Million)
Figure 79. Egypt DPT Series Vaccine Consumption Value (2021-2032) & (USD Million)
Figure 80. Saudi Arabia DPT Series Vaccine Consumption Value (2021-2032) & (USD Million)
Figure 81. South Africa DPT Series Vaccine Consumption Value (2021-2032) & (USD Million)
Figure 82. DPT Series Vaccine Market Drivers
Figure 83. DPT Series Vaccine Market Restraints
Figure 84. DPT Series Vaccine Market Trends
Figure 85. Porters Five Forces Analysis
Figure 86. Manufacturing Cost Structure Analysis of DPT Series Vaccine in 2025
Figure 87. Manufacturing Process Analysis of DPT Series Vaccine
Figure 88. DPT Series Vaccine Industrial Chain
Figure 89. Sales Channel: Direct to End-User vs Distributors
Figure 90. Direct Channel Pros & Cons
Figure 91. Indirect Channel Pros & Cons
Figure 92. Methodology
Figure 93. Research Process and Data Source
